eVusheld Assessment reaL wORld effectiveness in Israel Clalit Health Services

Trial Identifier: D8850R00002
Sponsor: AstraZeneca
Collaborator:
Clalit Health Services
NCTID:: NCT05712096
Start Date: March 2023
Primary Completion Date: May 2023
Study Completion Date: May 2023
Condition: COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Israel Ramat Gan, Israel